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Immune response (Ir) l genes associated with the murine major histocompati- 
bility complex (H-2) have been shown to control cellular and humoral responses 
to determinants on numerous T  cell-dependent antigens including simple syn- 
thetic amino acid copolymers (1-2) and complex natural proteins (3-6). In view 
of these findings and the relevance of the immune response to the pathogenesis 
of hepatitis B virus (HBV) infection and current vaccine programs, our laboratory 
has been investigating the role of Ir genes in regulating the immune responses 
to  antigenic  determinants  of hepatitis  B  surface  antigen  (HBsAg)  particles. 
HBsAg is a large (2.5-3.5 ×  l0  p mol wt) complex antigen possessing a common 
group-specific determinant, designated a, and two sets of subtype-specific deter- 
minants, d/y and w/r. The protein component is primarily composed of 25,000 
D (25 kD) protein and 30 kD glycoprotein polypeptide subunits with identical 
amino acid sequences (7). 
We have previously demonstrated that the humoral immune responses to the 
group-specific a  and subtype-specific d and y determinants of HBsAg are con- 
trolled by H-2-1inked Ir genes (8). High responder (H-2q'd), intermediate to low 
responder (H-2  a> b> k), and nonresponder (H-2  s'f) hapiotypes have been identified 
(9). The influence of an Ir gene(s) mapping in the I-A subregion on the primary 
antibody responses to both the a and d determinants of HBsAg and an additional 
influence of a gene(s) mapping to the right of the I-E subregion on at least the 
secondary anti-d response have been previously reported (8).  In this paper, we 
have investigated the kinetics and specificity of in vivo antibody production in 
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additional congeneic, H-2-recombinant strains immunized with HBsAg of the ad 
and ay subtypes in order to further delineate the map positions of the relevant 
Ir  genes  and  their  influence  on  the  immune  response  to  distinct  antigenic 
determinants on HBsAg. 
This current analysis indicates that the humoral anti-HBs response is regulated 
by at  least  two  H-2-1inked,  Ir  genes designated  Ir-HBs-1,  mapping  in  the  I-A 
subregion, and Ir-HBs-2, mapping in the I-C subregion (right of I-E and left of 
H-2D). A gene(s) mapping in the I-A subregion regulates the primary responses 
to all HBsAg determinants,  whereas the influence of the I-C subregional gene(s) 
appears to be determinant specific, primarily affecting the response to the d and 
3'  subtype-specific  determinants  of  HBsAg.  The  anti-a  response  is  regulated 
exclusively by Ir-HBs-1.  Strains  possessing only the  Ir-HBs-2 gene produce no 
anti-a  response, and a  subtype-specific antibody response is detected only after 
secondary or tertiary immunization.  In contrast, the influence of Ir-HBs-2 in the 
presence  of Ir-HBs-1  is  detected  upon  primary  immunization  and  is  additive 
rather than exclusive. There is also suggestive evidence that the presence of the 
E k molecule, at least in the context of I-A  k, may have a suppressive influence on 
the  anti-HBs  response.  These  data  indicate  that,  although  the  I-A  subregion 
exerts a dominant influence, distinct Ir genes, mapping in separate I subregions, 
control immune responses to alternate HBsAg determinants on the same protein 
molecule. 
In addition, the previous finding that HBsAg nonresponsiveness can be circum- 
vented by conjugation of HBsAg to a carrier moiety suggested the expression of 
Ir-HBs genes in helper T  cell function (10). Herein, we have initiated analysis of 
the  proliferative  T  cell  responses to  HBsAg in  responder,  nonresponder,  and 
(responder × nonresponder)F~, H-2 congeneic strains and confirmed H-2 restric- 
tion of HBsAg-specific T  cell proliferation. The kinetics and specificity of T  cell 
proliferative responses paralleled in vivo antibody production. 
Materials and Methods 
Mice.  C57BL/10 Sn (B10), B10.S(7R), B10.S(9R), B10.A(2R), B10.A(4R), B10.A(5R), 
B I 0.BR, D2.GD, A/J, A.TH, and A.TL murine strains were obtained from the breeding 
colony at the Research Institute of Scripps Clinic. B10.T(6R) and B10.HTT mice were 
provided by Dr.  Hugh McDevitt of Stanford University,  Palo Alto, CA and B10.S(8R), 
B10.RSF1, and  A.AL  mice  were provided  by Dr.  Chella  David  of the  Mayo  Clinic, 
Rochester, MN. Female mice between 6 and 8 wk of  age at the initiation of the experiments 
were used in all studies. 
HBsAg Preparations.  Preparations  of HBsAg pooled from (ad) or (ay) donors  were 
purified by a combination of ultracentrifugation, ammonium sulfate precipitation,  pepsin 
digestion,  and gel chromatography.  Since these are pooled HBsAg preparations, other 
subtype-specific determinants (ie., w/r) would be expected to be present.  However, upon 
immunization,  these preparations have elicited anti-a and anti-d or -y responses only. This 
may result from the immunization  dose, although the absence of anti-w or -r responses in 
guinea pigs immunized with  HBsAg subtypes has previously  been described (11). The 
HBsAg preparations  were free of contaminating  human  serum proteins  as tested by 
Ouchterlony analysis and immunoelectrophoresis against goat anti-human  serum. 
hnmunizations.  To study in vivo antibody production, groups of six mice were immu- 
nized  by intraperitoneal  injection  of 4.0  t~g of HBsAg in  0.2  ml  complete Freund's 
adjuvant (CFA) on day 0. They were bled from the retroorbital plexus on days 10 and 
24, boosted identically on day 30, and bled again  14 d after secondary immunization  (2°). M|LICH  ET AL.  43 
In vivo priming for the lymph node proliferative assay was accomplished by injection of a 
total of 16.0 #g of HBsAg in CFA in a volume of 80 #i into the two hind footpads of 
recipient mice. 
Measurement ofln Vivo Anti-HBs Production.  Serum antibody responses to HBsAg were 
measured by two methods. Pooled murine sera were evaluated for anti-HBs in an indirect, 
HBsAg subtype-specific, immunoglobulin class-specific,  radioimmunoassay (RIA)  using 
solid-phase HBsAg (ad or ay subtype) goat anti-mouse IgG and developed with a  '251- 
labeled, affinity-isolated swine anti-goat Ig (SAGG  -a~SI). The methodology, specificity, and 
sensitivity of this  solid-phase  RIA  have  been  previously described  (8,  9).  Titers are 
expressed as the reciprocal of log2 of the highest serum dilution to yield 2.5 times the 
counts of preimmunization sera. To analyze single murine serum samples for anti-HBs, a 
hemagglutination (HA) system was used. Human type O, Rh-negative erythrocytes were 
coated with HBsAg (ad or ay subtype) by the CrCls method (12) and added to 0.025 ml 
of serially diluted test sera in microtiter V-bottom plates. Results were expressed as the 
reciprocal of log,, of the highest serum dilution to yield agglutination. All anti-HBs assays 
were performed in 5-10% normal human serum to neutralize any possible antibodies to 
contaminating human plasma proteins that may not have been removed from the HBsAg 
preparation by the purification procedures. 
Pooled serum samples of strains demonstrating a fourfold difference in anti-HBs titer 
as measured by RIA were uniformly found to be significantly different (P <  0.01) when 
individual  serum  HA  titers  of these  strains  were  compared using  the  Student t  test. 
Therefore, a fourfold difference in RIA anti-HBs titer was considered statistically  signif- 
icant. 
Lymph Node Proliferation Assay.  An HBsAg subtype-specific proliferation assay  using 
draining popliteal  lymph  node cells was  modified from  the  method of Corradin  and 
Chiller  (13)  as  described previously (10).  Briefly, mice  were  immunized  in  the  hind 
footpads with  16 #g of HBsAg in CFA and draining popliteal lymph node (PLN) cells 
were harvested 8 d postimmunization. 4 ×  105 viable unfractionated PLN cells in 0.1  ml 
of Click's media (14) modified by the addition of Hepes (10 raM), gentamycin (10 #g/ml), 
and  0.5%  syngeneic mouse serum  were placed in  flat-bottom microtiter wells  (Falcon 
3072; Falcon Labware, Oxnard, CA) with 0.1  ml of HBsAg of the ad or ay sybtype (1.0- 
0.025 #g/ml) or culture media. Cultures were incubated for 5 d at 37°C in a humidified 
atmosphere of 5% COs in air and pulsed with  1 uCi [3H]thymidine (6.7 Ci/mmol; New 
England Nuclear, Boston, MA) 16-18 h before harvesting; proliferation was assessed  by 
incorporation of 3H into DNA. The data are expressed as: stimulation index (SI) -- cpm 
test antigen/cpm media control. The HBsAg-specific proliferative response of unfraction- 
ated  PLN  cells  harvested from  5  to  12  d  postimmunization  was  previously shown  to 
represent antigen-specific T  cell proliferation (10). 
To determine the effect of monoclonal anti-I-A reagents on T cell proliferation, HBsAg- 
primed, nylon column-passed PLN T  cells (4 ×  105) were cultured with HBsAg-pulsed, 
syngeneic, irradiated (2,500 rad) spleen cells (antigen-presenting cells) in the presence of 
various dilutions of anti-I-A reagents. MK-D6 (anti-I-A  a) and MK-S4 (anti-l-AS), originally 
from Kappler and Marrack (15) were generously provided by Dr. J. A. Berzofsky, National 
Institutes of Health. 
Results 
Complex Region  Gene Control of the Anti-HBs Response.  Regulation  of the  im- 
mune response to the group-specific a determinant of HBsAg has been tentatively 
mapped  to the  I-A/I-B subregion  of the H-2  complex, and  evidence has been 
suggested that additional I subregional loci may influence the secondary subtype- 
specific d response (8). To further delineate I  region gene control, the kinetics 
and  specificity of in  vivo antibody production  after HBsAg immunization  has 
been analyzed in a number of congeneic, H-2-recombinant strains. Groups of six 
mice  of each  strain  were  immunized  intraperitoneally  with  either  4.0  #g  of 44  DISTINCT  lr  GENES  INFLUENCE  RESPONSES TP  HBsAg 
HBsAg/ad or HBsAg/ay and individual and pooled serum anti-HBs/ad or anti- 
HBs/tty, and anti-HBs/a titers were determined at days 10 and 24 (1°), and after 
secondary immunization (2°). In some instances, tertiary (3 °  ) immunizations with 
HBsAg/ay were  given  due  to  the  reduced  immunogenicity of HBsAg/ay as 
compared with the ad subtype. 
The IgG anti-HBs titers of B 10 congeneic, H-2 recombinant strains immunized 
with  HBsAg/ad or  HBsAg/ay are  presented  in  Figs.  1  and  2,  respectively. 
Relevant H-2 region and subregion alleles are shown for convenience. The B 10 
strain  responded  to  the  a,  d,  and  y  determinants  of  HBsAg  after  primary 
immunization and IgG class antibodies were detected by day 24. The B10.T(6R) 
strain,  likewise, responded to all  three determinants of HBsAg; however, IgG 
class anti-a- and anti-d- or anti-y-specific antibodies were detected as early as day 
10.  This  early  IgG  response  pattern  is  exclusively characteristic of the  high 
responder H-2  q and  H-2  d haplotypes  (9).  Secondary anti-HBs  titers  were not 
significantly different between  mice of the  B10  and  B10.T(6R)  strains.  The 
B 10.S(7R) strain was totally nonresponsive to all HBsAg determinants even after 
secondary or tertiary immunization. Since the B 10.T(6R) and B10.S(7R) strains 
share H-2D  d, the D region is not involved in regulation of the anti-HBs response. 
The B10.S(9R) strain produced no primary or secondary anti-a response; how- 
ever, a secondary anti-d and a tertiary anti-y response in 50% of mice immunized 
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FIGURE  1.  In vivo anti-HBs production  in congeneic, H-2 recombinant strains of the BI0 
series  after  HBsAg/ad  immunization.  Groups  of  six  mice  of  the  indicated  strains  were 
immunized and boosted with 4.0 ~g i.p. of HBsAg/ad.  Sera from primary, 10-d (closed bars), 
24-d (1°; open  bars),  and  secondary (2°; hatched bars) bleedings were analyzed for anti-ad- 
(left) and anti-a- (right) specific antibody by RIA. Titers are expressed as the reciprocal of the 
log~ of the highest serum dilution to yield 2.5 times the counts of preimmunization sera. Only 
positive sera were pooled for RIA determination; unless otherwise noted (i.e., %),  100% of 
individual sera  were positive by HA before pooling. The relevant  major histocompatibility 
complex region and subregion alleles of each strain are shown. MILICH  ET  AL.  45 
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FIGURE 2.  In vivo anti-HBs production  in congeneic, H-2 recombinant strains of the B10 
series after HBsAg/ay immunization. Groups of six mice of the indicated strains were immu- 
nized and boosted either once or twice with 4.0 eg Lp. of HBsAg/ay.  Sera from primary, 10- 
d (closed bars), 24-d (1 °; open bars), secondary (2°; hatched bars) or tertiary (3°; cross-hatched 
bars)  bleedings were analyzed for anti-ay- (left) and anti-a- (right) specific antibody  by  RIA. 
Titers are expressed as the reciprocal of the Iog~ of the highest serum dilution to yield 2.5 
times the counts of preimmunization sera. Only positive sera were pooled for RIA determi- 
nation; unless otherwise noted (i.e., %),  100% of individual sera were positive by HA before 
pooling. The relevant major histocompatibility complex region and subregion allele of each 
strain are shown. 
with HBsAg/ad or HBsAg/ay, respectively, was observed. In response to HBsAg/ 
ad immunization, the B10.HTT strain differed only slightly from the B10.S(9R) 
strain, with a fourfold lower secondary anti-d response in 50% of the recipients 
(Fig.  1). However, with respect to the anti-y response, the B10.HTT strain was 
totally nonresponsive after three HBsAg/ay immunizations, whereas 50% of the 
B10.S(9R) strain responded to the third immunization with an anti-y response 
(Fig. 2). Similar to the B10.S(9R) strain, the B10.HTT strain produced no anti° 
a response even after tertiary immunization with HBsAg of either subtype. 
Comparison of the responses of the B 10.S(9R) and B 10.S(7R) strains indicates 
that control of the anti-a response maps to I-A/I-B (H-2K irrelevant; see below), 
since the presence of the nonresponder s allele in I-A/I-B is sufficient to preclude 
an  anti-a-specific  antibody  response.  The  responses  of  the  B10.S(9R)  and 
B10.HTT  strains suggest that a  gene(s) to the right of the I-B subregion can 
influence the  secondary anti-d/y responses.  Therefore,  it  was  of interest  to 
determine if the presence of nonresponder alleles to the right of I-B would affect 
the anti-d or anti-y responses in the context of a responder allele in I-A/LB. The 
B10.S(8R) strain was analyzed and positive primary anti-a, -d, and -y responses 
were observed at day 24 (Figs.  1 and 2). Note also the B10.S(8R) strain, similar 
to all strains that produce an a-specific response, demonstrated an antisubtype 
response of greater magnitude than the group-specific anti-a response at all time 46  DISTINCT  Ir  GENES INFLUENCE RESPONSES TP  HBsAg 
points. The B 10.S(8R) strain results indicate that a responder allele in I-A/I-B is 
sufficient to  confer  responsiveness  to  all  HBsAg  determinants  after  primary 
immunization. Similarly, the D2.GD strain (not congeneic to B10) possesses the 
same I-E  b, I-C  b subregional loci as the nonresponding B 10.RSF 1 strain. However, 
the presence of the I-Ad/I-B  ~ subregion produced a characteristic high responder 
phenotype (10  d,  IgG, anti-a  and anti-d) indicating the dominant influence of 
the I-A/I-B subregion on the anti-HBs response (Fig. 3). Most likely the relevant 
Ir gene(s) maps to the I-A rather than the I-B subregion since monoclonai anti- 
I-A of the appropriate specificity significantly inhibits the y- and a-specific T  cell 
proliferative responses in BALB/c mice (Table I). Note that the anti-I-A  e mono- 
clonal  supernatant  (MK-D6)  quantitatively inhibited  both  the  group-specific  a 
and the subtype-specific y proliferative responses, but that a-specific proliferation 
was inhibited to a  greater extent. Therefore, in the case of the BALB/c strain 
(H-2d), an  I-Ad-encoded molecule(s) is relevant to both a- and y-specific T  cell 
responses. 
Influe~zce of the  I-A  a~d  I-C  Subregions  on  the  Anti-HBs/ad  Responses  in  H-2 
Recombinant  Strab~s on an A  Genetic Background.  The B10.S(9R) and B10.HTT 
H-2 congeneic strains differ within the I region only at the I-J and I-C subregions, 
yet  demonstrated  quantitative  differences  in  anti-d  responses  and  qualitative 
differences with respect to anti-y responsiveness (B10.HTT  was nonresponsive 
to  the  y  determinant).  To  examine  the  influence  of the  1-C  subregion,  we 
compared the in vivo antibody responses to HBsAg/ad immunization in A/J (I- 
C a) and A.AL (I-C  k) H-2 congeneic strains, which express an I region difference 
Strain 
BIO.A(2R) 
I  i'  • 
KABJECD 
kkkkkdb 
BIO.BR  kkkkkkk 
BIO.Ai4R}  kkbbbbb 
BIO.A(5R)  bb'bkkdd 
BIO,RSF1  ss,.bbf 
D2.GD  dddbbb'b 
Time  Anti.HBslad Titer (1/Iogz)  Anti-HBs/a  Titer (l/Iogz) 
0  4  8  1=2  16  t  0  4  8  12  16 
:2048~f,//A 
20  ~1:11[1'384~'///A  ~//.,,tl 
lOd~ 
2  °  V//.~t;2~4ff///A  :812///A 
2  o  V///I/A:3ZflOSr////A  a4Og~,rl//A 
L 
I  1:128  I 
V////~1:1 ~,,364¢////A 
10 d.  10  1:2048  I 
20  ~J"///~:65,536~/////A 
10 d. 
1' 
2  = 
~///,,JI:BI  9Z"f///A 
FIGURE 3.  In vivo anti-HBs production in congeneic, H-2 recombinant strains of the B10 
series afer HBsAg/ad immunization. Groups of six mice of the indicated strains were immu- 
nized and boosted with 4.0 ug of HBsAg/ad. Sera from primary, 10-d (closed bars), 24-d (1 o; 
open bars), and secondary (2°; hatched bars) bleedings were analyzed for anti-ad- (left) and 
anti-a- (right) specific antibody by RIA. Titers are expressed as the reciprocal of the log2 of 
the highest serum dilution to yield 2.5 times the counts of preimmunization  sera. The relevant 
major histocompatibility  complex region and subregion alleles of each strain are shown. MILICH  ET  AL.  47 
TABLE  I 
Effect of Monoclonal Anti-I-A Reagents on the HBsAg-specific Proliferative Responses of BALB/c 
T Cells Reconstituted with BALB/c Antigen-presenting Cells 
In vitro antigen-presenting 
T  cell  Anti-la  Dilution  cell pulse* (cpm) 
HBsAg/ay  HBsAg/ad  Media 
HBsAg/ay-primed  0  --  24,000  14,000 
Percent suppression 
Anti-l-A  d*  1:10  99  100  -- 
1:80  62  100  -- 
1:320  43  82•3  -- 
1:10  0  0  -- 
1:80  0  0  -- 
Anti-I-A  ~ 
3,000 
* HBsAg-ay-primed, nylon column-passed PLN T cells (4 X 105) were cultured with (2 x  10  s) HBsAg/ 
a~'- or HBsAg/ad-putsed syngeneic, irradiated (2,500 rad) spleen cells (antigen-presenting cells) in 
tlae presence of the indicated dilutions of anti-l-A reagents, and the proliferative responses were 
determined after 5 d in culture. 
* MK-D6 (monoclonal supernatant; private specificity). 
§  r  MK-S4 (monoclonal supernatant; cross-reacts with I-A  only). 
I 
Strain  KA8JE(~D Time  Anti.HBs/ad Titer (Ulog2)  Anti-HRs/a  Titer (l/IogzJ 
0  4  8  12  16  0  4  8  12  16 
A/J  kkkkkdd  10d  °  .  '~  '  '  ~  '  '  ' 
20  ,536y/7//A  :4096y~/~//A 
A.AL  kkkkkkd  10 1~  ~  ~/z 
2  0  4os6~//,¢,,'J  1:256~//A 
A.TL  s~rkkkkd 101d. ~,12  ~ 
20  o4~.///A 
'.t'-'  --d  L  i  2 0  1:4  1:4 
FIGURE 4.  In vivo anti-HBs production of congeneic, H-2 recombinant strains of the A series 
after HBsAg/ad immunization. Groups of six mice of the indicated strains were immunized 
and boosted with 4.0 t~g of HBsAg/ad. Sera from primary, 10-d (closed bars), 24-d (1°; open 
bars), and secondary (2°; hatched bars) bleedings were analyzed for anti-ad- (left) and anti-a- 
(right) specific antibody by RIA. Titers are expressed as the reciprocal of the log2 of the highest 
serum dilution to  yield 2.5  times the counts of preimmunization sera.  The relevant major 
histocompatibility complex region and subregion alleles of each strain are shown. Note the 
A.TL strain I-A subregion is depicted as ,k, which refers to the H-2' and H-2  k origins of the 
A~ polypeptide chain of this strain. 
only in the I-C subregion• As shown in Fig. 4, the primary and secondary anti-d 
responses of the A/J strain were 16-fold greater than the anti-d responses of the 
A.AL strain.  The anti-a response also appeared to be significantly influenced by 
the  I-C  d subregion  allele,  although  this  is  not  a  consistent  finding  (discussed 
below)• Comparison of the A/J and A.AL strain responses illustrates the signifi- 
cance of the I-C subregion to the anti-HBs response and demonstrates a differ- 
ence between the  I-C  d and  I-C  k alleles• Additionally,  these results demonstrate 48  DISTINCT  Ir  GENES  INFLUENCE  RESPONSES  TP  HBsAg 
that the influence of the I-C  a allele on the anti-d response in the context of a 
responder allele  in  I-A  (I-A  k)  is  additive and  can  be  detected after  primary 
immunization. In contrast, the influence of the I-C  a allele in the context of a 
nonresponder allele in I-A [i.e., B 10.S(9R)] is exclusive and can only be detected 
after secondary immunization. 
Comparison of the A.TH and A.TL strains illustrates the irrelevance of the 
H-2K region since both strains possess the H-2K  ~ region and the A.TL strain is 
an HBsAg responder, whereas the A.TH strain is a nonresponder (Fig. 4). The 
A.AL and A.TL strains were compared because part of the A, polypeptide chain 
of the A molecule in the A.TL strain is of H-2' haplotype (nonresponder) origin 
rather than H-2 k haplotype origin due to a possible intragenic recombinant event 
(16), and it was of interest to determine if the derivation of the A~ polypeptide 
component of the I-A-encoded A molecule influenced the anti-HBs response. As 
shown in Fig. 4, the A.AL and A.TL strains were not significantly different in 
their responses to the a or d determinants of HBsAg, suggesting that a determi- 
nant on the Ae or nonrecombinant part of the A~ polypeptide chain is associated 
with the recognition of HBsAg. 
Relevance of the I-C Subregion on Anti-HBs/ad Responses in H-2 Recombinant Strains 
on a BIO Genetic Background and Possible Negative Influence of the I-E*/I-C  k Subre- 
gion.  Comparison  of in  vivo  anti-HBs/ad  production  between  B10.BR  and 
B10.A(2R)  strains,  which differ significantly only in  the I-C subregion (H-2D 
irrelevant), confirmed that a gene(s) influencing the anti-d response maps to the 
I-C subregion (Fig. 3). The B 10.A(2R) strain (I-C  d) produced an eightfold greater 
24-d primary anti-d response than the B10.BR strain (I-Ck). The secondary anti- 
d  response of the B10.A(2R)  strain was also eightfold higher than that of the 
B 10.BR strain. The primary anti-a response was not influenced by the I-C  d allele, 
but the B10.A(2R) secondary anti-a response was fourfold greater than that of 
the BI0.BR strain. 
Previous studies of in vivo anti-HBs production in the C3H and CBA strains 
(9) and the response of the B10.BR H-2 congeneic strain indicate that the H-2  k 
haplotype confers low responsiveness to HBsAg.  However, the B10.S(8R) and 
B10.A(4R) strains produced 16-fold greater primary anti-d responses than the 
B10.BR strain (Figs.  1 and 3).  Like B10.BR,  these strains possess the I-A  k sub- 
region, but unlike B10.BR,  they do not express an E  k molecule. These results 
suggest the possibility that I-E  k, at least in the context of I-A  k, may be suppressive. 
If expression of an  E  k molecule is  suppressive,  it appears  that an Ee  k chain is 
required, since the B10.A(5R)  strain  (I-A  b,  I-E  k) produces a  vigorous primary 
and secondary anti-HBs response (Fig. 3). It should be noted that the B10.S(8R) 
and B 10.A(4R) strains also lack the I-C  k subregion as compared with the B10.BR 
strain; possession of I-C  k cannot be ruled out as possibly relevant to the "inferior" 
B10.BR response. 
H-2 Restriction  of T Lymphocyte Proliferative  Responses to the a and d Determinants 
of  HBsAg.  To examine the role of H-2-1inked Ir genes in regulating the response 
to HBsAg determinants at the T cell level, the HBsAg-specific T cell proliferative 
responses of H-2 congeneic B 10.T(6R) responder, B 10.S(7R) nonresponder, and 
(responder x  nonresponder)Fl  mice were analyzed. Groups of four mice were 
primed with  HBsAg/ad  (16  #g)  in  vivo and pooled  PLN  cells harvested 8  d MILICH  ET  AL.  49 
postimmunization  and  challenged  in  vitro  with  HBsAg/ad  or  HBsAg/ay to 
determine  the  ad-  and  a-specific  T  cell  proliferative  responses,  respectively. 
B10.T(6R)  mice  demonstrated  significant  d-specific  proliferation  (SI,  3.0)  at 
HBAg/ad concentrations from 0.05  to  1.0 #g/ml and required  10-fold higher 
HBsAg/ay doses to induce significant a-specific proliferation, which was consist- 
ently of lower magnitude (Fig. 5). In contrast, the B 10.S(7R) strain demonstrated 
no HBsAg-specific T  cell proliferative responses at 8 d  postimmunization, and 
the  12-d response was also negative (data  not shown). The (R  X  NR)FI  mice 
produced ad- and a-specific proliferative responses equivalent to the B 10.T(6R) 
responder parent. 
Discussion 
The analysis of H-2 recombinant strains immunized with HBsAg of ad and ay 
subtypes indicates that at least two distinct Ir genes influence antibody production 
to determinants on the same HBsAg molecule. An Ir gene(s) mapping in the I- 
A  subregion  regulates  responsiveness to all  antigenic determinants of HBsAg 
(group-specific a  and  subtype-specific d  or y) after  primary  immunization; we 
have designated it Ir-HBs-1. The presence of a responder allele in I-A conferred 
responsiveness  to  the  a,  d,  and  y  determinant  after  primary  immunization, 
whereas the presence of a  nonresponder allele in I-A conferred nonresponsive- 
ness to all three HBsAg determinants after primary immunization. Mapping the 
regulation of the anti-a response to the I-A subregion was confirmed by the fact 
that all H-2 recombinant strains possessing the I-A  s allele were nonresponsive to 
the a determinant even after hyperimmunization and regardless of the presence 
of a  responder haplotype at other subregional loci. In contrast, secondary im- 
munization of recombinant strains lacking Ir-HBs-1  revealed the influence of an 
Ir gene(s) on the subtype-specific anti-d or anti-y responses mapping in the I-C 
subregion; we have designated this gene Ir-HBs-2. For example, B 10.S(9R) mice 
produce an  exclusive antisubtype-specific response after  secondary or tertiary 
immunization with HBsAg of the ad or ay subtype without concomitant anti-a 
~ 'lO ~F~ 
=~  B  10.T(6R) 
~BIO.SI7R) 
.~  ~l.1 0.25  015  1;0 
HBsAg (~gtml) 
FIGURE .5.  HBsAg-specific T  cell-proliferative responses of B 10.T(6R) responder, B l 0.S(7R) 
nonresponder, and F]  H-2  congeneic, strains. Groups of four mice of the indicated strains 
were immunized with  16 #g of HBsAg]ad in CFA, and 8  d  later PLN cells were harvested 
and stimulated in vitro with HBsAg/ad (closed symbols) or HBsAg/ay (opensymbols). The 
HBsAg-specific proliferative responses are expressed as a  stimulation index (SI  =  cpm test 
antigen/cpm media control. Media controls ranged from 1,000 to 5,000 cpm. 50  DISTINCT Ir  GENES INFLUENCE RESPONSES TP  HBsAg 
production.  The  significantly  different  primary  anti-d  responses  of the  H-2 
recombinant strains possessing the same responder allele in the I-A (I-A  k) subre- 
gion and differing only in the I-C subregion [B10.A(2R) vs. B10.BR and A/J vs. 
A.AL] demonstrated that the influence of Ir-HBs-2 in the context ofa responder 
allele  in  I-A  (Ir-HBS-1)  is additive  rather  than  exclusive and  can  be detected 
after primary immunization.  Quantitative differences are observed between the 
I-C  e  and  I-C  k alleles  when  these  strains  were  compared  after  primary  and 
secondary immunization with HBsAg/ad.  The I-C  a allele conferred superior anti- 
d responsiveness as compared with the I-C  k allele in both strain combinations. In 
addition, quantitative differences were observed between the I-C  d and I-C  k alleles 
when  the  BI0.S(9R)  and  B10.HTT  strains  were  immunized  with HBsAg/ad. 
Qualitative  differences  were  seen  when  these  strains  were  immunized  with 
HBsAg/ay: the B10.HTT strain  was totally nonresponsive, whereas 50% of the 
B10.S(9R)  mice  produced  anti-y-specific  antibody.  The  observation  that  the 
B I 0.HTT strain (I-C  k) responded to the d determinant and not the y determinant 
upon hyperimmunization  is also of interest. It has been suggested that the d and 
y determinants  of HBsAg may differ by as few as two amino acid residues (17, 
18), yet the I-C  k allele permitted responsiveness to the d but not they determinant. 
This may provide insight into mechanisms of possible interaction  between I-C- 
encoded molecules and restricted domains on HBsAg. The greater responses of 
the B 10.A(4R) strain (I-A  k, I-C b) and the B10.S(8R) strain (I-A  k, I-C  s) compared 
with the B10.BR strain (I-A  k, I-C  k) may relate to the I-E subregional differences 
expressed by these strains.  Therefore,  while the comparisons  of A/J vs.  A.AL 
and  B10.A(2R) vs.  B10.BR strains,  which  share  the  I-E  k allele,  illustrate  the 
relevance of the I-C subregion, it cannot be assumed that additional mechanisms 
are not operative in strains differing at I-E.  For example, the presence of I-E  k- 
restricted T  suppressor cells in the lactate dehydrogenase B system was recently 
demonstrated (19). 
The  observations of ~50%  responsiveness in  strains  possessing a  responder 
allele in I-C in the context ofa nonresponder allele in I-A [B10.S(9R), B10.HTT] 
is difficult to assess. We have observed this heterogeneity in two different H-2- 
recombinant  strains  involving a  total  of 33  mice  in  response  to  two separate 
antigens  (d and y) and  suggest  it  may be  more  than  artifactual.  Evidence  for 
classifying these strains as responsive to HBsAg comes from the fact that  upon 
further  hyperimmunization,  at  least minor antisubtype responses are observed 
in virtually  100%  of mice as well as low titer anti-a  responses in some mice.  A 
similar observation has been made in the sperm whale myoglobin (Mb) system, 
involving the B10.HTT strain,  wherein it was suggested that  nonresponse was 
more likely an artifact than response and that the strain was considered responsive 
(20).  We are currently conducting genetic analysis of (9R) responder and  (9R) 
nonresponder mice to resolve this issue. In any event, the validity of the concept 
of dual Ir gene control does not rely solely on the response status of the B 10.S(9R) 
and B10.HTT strains, as discussed previously. 
Cumulatively, these genetic data clearly indicate the existence of at least two 
H-2-1inked Ir genes regulating  the response to HBsAg determinants,  one map- 
ping in the I-A subregion and the other in the I-C subregion. It should be noted 
that  we provide no formal evidence that  gene(s) to the right  of I-C and  to the MILICH  ET  AL.  51 
left of H-2D are not involved in regulation of the response to HBsAg, and use 
the term "I-C subregion" in this broad sense. However, a  question arises as to 
whether the gene(s) mapping in the I-C subregion (Ir-HBs-2) effects the anti-a 
response as well as the anti-d/y responses, since the I-C subregion allele appeared 
to influence the anti-a response in certain recombinant strains. We suggest that 
Ir-HBs-2  does  not directly regulate the anti-a  response  because: (a) no anti-a 
responses are detected in the absence of Ir-HBs-1; (b) the presence of the high 
responder I-C  d allele did not affect the anti-a response in all recombinant strains 
and;  (c) anti-I-A  ~ monoclonal antibody incompletely inhibited  the y-specific T 
cell proliferative response of BALB/c (H-2  d) mice possessing both Ir-HBs genes, 
but  totally abrogated the anti-a-specific proliferative response, suggesting that 
the anti-a response is exclusively restricted by the I-A subregion. The apparent 
influence of the I-C subregion on the anti-a response may reflect T  cell helper 
activity directed to the d or y determinants that nonspecifically amplifies the anti- 
a response. 
Although  these  genetic  experiments  were  analyzed  by  measuring  in  vivo 
antibody production, the T  cell proliferative responses to the a and d determi- 
nants of HBsAg were H-2-restricted and the kinetics and specificity of the T  cell 
responses paralleled those of in vivo antibody production. For example, the d- 
specific proliferative responses preceded and were of greater magnitude than 
the a-specific proliferative responses:  In  addition,  the responses of the  (R  x 
NR)FI  mice indicated that HBsAg-specific T  cell proliferation is inherited as a 
dominant trait with no gene dosage effects as observed for antibody production 
(9).  These  results, the T  dependent nature of HBsAg  (21),  and the fact that 
nonresponsiveness to HBsAg can be circumvented by conjugation to a  carrier 
moiety (10) establish that lr-HBs genes are expressed at the T  cell level. 
The regulation of the immune response to  HBsAg bears some remarkable 
similarities with other Ir gene-restricted, naturally occurring, protein antigens. 
The immune response to hen egg lysozyme (HEL) is controlled by two Ir gene 
loci,  one  in  the  I-A and  the  other believed to  be  in  the  I-C  subregion  (22). 
Differential effects between I-C  d and I-C  k alleles in the HEL system have been 
reported as  well  (23).  The  murine antibody and  T  lymphocyte proliferative 
response to Mb were found to be under the control of two distinct H-2-1inked Ir 
genes, one mapping in the I-A subregion (Ir-MB-1) and the other mapping in 
the I-C subregion (Ir-Mb-2) (24). Furthermore, H-2-recombinant strains possess- 
ing only the Mb responder allele in I-A were responsive to all cyanogen bromide 
cleavage fragments, whereas strains possessing only the Mb responder allele in 
I-C responded to the  NH2-terminal fragment but not to the COOH-terminal 
fragment, and these responses were evaluated after secondary or tertiary im- 
munization (24).  Therefore, similar to  the HBsAg system, the I-A responder 
allele confers full  responsiveness  to  Mb,  and  the  I-C  responder allele  in  the 
absence of an I-A responder allele confers responsiveness to fewer or a subset of 
determinants. 
Any hypothesis regarding the relationship of I-A and I-C subregional loci and 
their influence on the regulation of responsiveness to a multideterminant, protein 
antigen  such  as  HBsAg  must  explain  the  predominant  influence of the  I-A 
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I-C subregion on  the responses to  the subtype-specific determinants.  Multiple 
independent Ir genes mapping in I-A that regulate the a, d, and y responses seem 
unlikely in view of the fact that H-2  s'r hapiotype-bearing strains are nonresponsive 
to all HBsAg determinants. The I-C subregion may encode immune suppressor 
genes.  Such a  role  for the  I-C  subregion in  the control of the generation of 
suppressor T  cells (Ts) in the mixed lymphocyte reaction has been proposed (25). 
Additionally, I-C subregion-encoded suppressor factors have been reported to 
regulate  lymphokine  production  (26)  and  contact  sensitivity  (27).  Although 
nonresponders  to  HBsAg  can  be  induced  to  produce  anti-HBs  in  vivo  by 
alteration of the route as well as dose of immunization, we have been unable to 
demonstrate a role for Ts cells in HBsAg nonresponsiveness (10).  However, we 
are continuing to explore this possibility as it may apply to the influence of the 
I-E/I-C subregions. Regarding the influence of the I-A subregion, an hypothesis 
consistent with existing data predicts the existence of a T  cell "carrier determi- 
nant"  on  HBsAg,  recognized by  helper T  (Th)  cells in  the context of an  Ia 
molecule encoded within the I-A subregion. Such Th cells may be able to provide 
functional help to  B cell clones specific for the a,  d,  and y epitopes. There is 
increasing evidence that T  cell determinants on a molecule can be distinct from 
B  cell  determinants or antibody-binding sites  in  a  variety of antigen  systems 
including, glucagon (28), insulin (29), 13-galactosidase  (30),  lysozyme (31),  myo- 
globin (32),  and the encephalomyelitogenic, myelin basic protein peptide (33). 
In this regard, immunization of mice (10) and rabbits (18) with keyhole limpet 
hemocyanin-conjugated synthetic  peptide  analogues  of HBsAg  determinants 
induced significant anti-HBs responses. In contrast, immunization of mice with 
free synthetic peptide analogues of the d and y determinants of HBsAg induced 
minimal antibody responses and did not distinguish H-2  q from H-2 s haplotype- 
bearing strains (10).  These data suggest that these synthetic B cell epitopes do 
not possess T cell determinants, and therefore, Ir-restricted, T cell helper activity 
is absent. Indeed, evaluation of the immune response to chemically synthesized 
peptide  fragments of HBsAg  suggests  the  existence of distinct T  and  B  cell 
epitopes on HBsAg (manuscript in preparation). With respect to native HBsAg, 
a  responder allele in I-A may result in carrier-specific help engaging all deter- 
minant-specific B cell clones. The concept of a  T  cell carrier determinant on 
HBsAg need not exclude the existence of determinant-specific Th or Ts cells 
specific for d  or y determinants and restricted by the I-E/I-C subregion.  The 
presence of a  nonresponder allele in  I-A would preclude carrier-specific help 
and may necessitate secondary or tertiary immunization to expand smaller d/y 
determinant-specific T cell precursor pools, which may selectively cooperate with 
determinant-specific B cell clones. Strains possessing both Ir-HBs genes would 
reflect an additive rather than exclusive effect of Ir-HBs-2. 
The difficulties in demonstrating I-C-encoded, serologically detectable mole- 
cules have  prompted  questioning of the existence of the  I-C  subregion  (34). 
However, the recent demonstration of xenoantisera that detect I-C  d- and I-C  b- 
encoded products (35) and the observation that at least three Ir gene-restricted, 
multideterminant, naturally occurring protein antigens are influenced by genes 
mapping in the I-C subregion clearly support the existence of an I-C subregion. 
The  consistent  involvement of the  I-C  subregion  and  the  similarities  of the MILICH  ET  AL.  53 
regulation of the immune response to these protein antigens suggest a  unique 
influence of this subregion on responses to naturally occurring protein antigens 
that may not be relevant to simple copolymer antigens. 
The results of these investigations raise several questions regarding the mech- 
anism of responsiveness to HBsAg. How do distinct Ir genes regulate the response 
to  different determinants on  the  same  molecule? What  is  the nature  of the 
determinant(s) recognized by T  helper cells and B cells? What is the mechanism 
of I-C subregion influence? In addition, the evidence of multiple I-region gene 
control of the murine immune responses to HBsAg provides a  model to more 
adequately understand the complex and variable human immune responses to 
HBsAg after vaccination as well as during the course of HBV infection. In this 
regard, it is notable that an association between HLA-DR phenotype and non- 
responsiveness to a  trial  HBsAg vaccine has been reported (36),  and a  human 
HBsAg  vaccine recipient  was  observed to  produce an  anti-d  response  in  the 
absence of an anti-a response (37). These preliminary findings suggest that, after 
immunization, distinct Ir genes may influence regulation of the human immune 
response to the a and d determinants of HBsAg, as demonstrated herein for the 
murine immune response. 
Summary 
We have previously demonstrated that the murine humoral immune responses 
to the group-specific a and subtype-specific d/y determinants of hepatitis B surface 
antigen (HBsAg) are controlled by H-2-1inked immune response (Ir) genes. High 
responder (H-2d'q), intermediate responder (H-2  a > b > k) and nonresponder (H- 
2 r's) haplotypes have been identified (8, 9). The kinetics and specificity of in vivo 
antibody production after HBsAg immunization in congeneic, H-2-recombinant 
strains was analyzed to further define relevant Ir genes and their influence on 
the immune response to distinct antigenic determinants. 
These studies indicate that the humoral anti-HBs response is regulated by at 
least  two  Ir  genes,  one  in  the  I-A  subregion  (Ir-HBs-1)  and  one  in  the  I-C 
subregion (Ir-HBs-2) of the murine H-2 complex. Ir-HBs-1 regulates the primary 
responses  to  all  HBsAg  determinants,  whereas  the  influence of Ir-HBs-2  is 
determinant specific, affecting the responses to the d  or y determinants. The 
anti-a response is regulated exc_lusively by Ir-HBs-1.  Strains possessing only the 
Ir-HBs-2  gene  [B10.S(9R)  and  B10.HTT]  produce no anti-a  response and  a 
subtype-specific antibody response is detected only after secondary or tertiary 
immunization. In contrast, the influence of Ir-HBs-2 in the presence of Ir-HBs- 
1 is detected upon primary immunization and is additive rather than exclusive. 
There is also suggestive evidence that the presence of the E  k molecule, at least 
in the context of I-A  k, may have a suppressive influence on the anti-HBs response. 
Additionally, HBsAg-specific, T  cell proliferative responses were H-2 restricted 
and the kinetics and specificity of T  cell proliferative responses paralleled in vivo 
antibody production. These data indicate that, although the I-A subregion exerts 
a dominant influence, distinct Ir-HBs genes, mapping in separate I subregions, 
control immune responses to alternate HBsAg determinants on the sameprotein 
molecule. 54  DISTINCT Ir GENES INFLUENCE  RESPONSES TP  HBsAg 
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